EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions

Pina Ziranu, Andrea Pretta iD, Giorgio Saba, Dario Spanu, Clelia Donisi, Paolo Albino Ferrari iD, Flaviana Cau iD, Alessandra Pia D'Agata, Monica Piras iD, Stefano Mariani iD, Marco Puzzoni, Valeria Pusceddu iD und 3 weitere

International Journal of Molecular Sciences · 06.08.2025 · 26 (15) · 7619

DOI: 10.3390/ijms26157619 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.08.2025. Verfasst von Pina Ziranu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liquid Biopsy, Biomarkers, Tumor. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 335 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy has emerged as a valuable tool for the detection and monitoring of colorectal cancer (CRC), providing minimally invasive insights into tumor biology through circulating biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). Additional biomarkers, including tumor-educated platelets (TEPs) and exosomal RNAs, offer further potential for early detection and prognostic role, although ongoing clinical validation is still needed. This review summarizes the current evidence on the diagnostic, prognostic, and predictive capabilities of liquid biopsy in both metastatic and non-metastatic CRC. In the non-metastatic setting, liquid biopsy is gaining traction in early detection through screening and in identifying minimal residual disease (MRD), potentially guiding adjuvant treatment and reducing overtreatment. In contrast, liquid biopsy is more established in metastatic CRC for monitoring treatment responses, clonal evolution, and mechanisms of resistance. The integration of ctDNA-guided treatment algorithms into clinical practice could optimize therapeutic strategies and minimize unnecessary interventions. Despite promising advances, challenges remain in assay standardization, early-stage sensitivity, and the integration of multi-omic data for comprehensive tumor profiling. Future efforts should focus on enhancing the sensitivity of liquid biopsy platforms, validating emerging biomarkers, and expanding multi-omic approaches to support more targeted and personalized treatment strategies across CRC stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiquid BiopsyBiomarkers, TumorHumansNeoplasm, ResidualTreatment OutcomeEarly Detection of Cancer

Stichwörter der Autor:innen

adjuvant therapy guidancecolorectal cancerliquid biopsyminimal residual diseaseresistance mechanisms

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Medical Oncology Unit, University Hospital and University of Cagliari, 09042 Cagliari, Italy.
  • Division of Thoracic Surgery, Azienda di Rilievo Nazionale ed Alta Specializzazione "G. Brotzu", 09121 Cagliari, Italy.
  • Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
  • Clinical-Microbiological Laboratory, University Hospital of Cagliari, 09042 Cagliari, Italy.
  • Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

ORCID-Profile: Andrea Pretta, Paolo Albino Ferrari, Flaviana Cau, Monica Piras, Stefano Mariani, Valeria Pusceddu, Gavino Faa, Mario Scartozzi

Zitieren

APA

Ziranu, P., Pretta, A., Saba, G., Spanu, D., Donisi, C., Ferrari, P. A., Cau, F., D'Agata, A. P., Piras, M., Mariani, S., Puzzoni, M., Pusceddu, V., Coghe, F., Faa, G., & Scartozzi, M. (2025). Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions. International Journal of Molecular Sciences, 26(15), 7619. https://doi.org/10.3390/ijms26157619

Vancouver

Ziranu P, Pretta A, Saba G, Spanu D, Donisi C, Ferrari PA, et al. Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions. International Journal of Molecular Sciences. 2025;26(15):7619. doi:10.3390/ijms26157619

BibTeX
@article{Ziranu2025,
  author = {Ziranu, Pina and Pretta, Andrea and Saba, Giorgio and Spanu, Dario and Donisi, Clelia and Ferrari, Paolo Albino and Cau, Flaviana and D'Agata, Alessandra Pia and Piras, Monica and Mariani, Stefano and Puzzoni, Marco and Pusceddu, Valeria and Coghe, Ferdinando and Faa, Gavino and Scartozzi, Mario},
  title = {Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7619},
  doi = {10.3390/ijms26157619}
}
Kostenlos starten →